Literature DB >> 20887223

Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals.

Kristina Broliden1.   

Abstract

Sexual transmission is the single most common mechanism for acquiring infection with human immunodeficiency virus (HIV), and the efficiency of transmission reflects the biology of the mucosal site. The localization and phenotypic characterization of HIV target cells and receptors and the presence of immune molecules are therefore important to define at sites of HIV exposure. To complicate the picture, HIV‐binding receptors and antiviral immune molecules can be protective under certain circumstances but can exert an opposite effect at other mucosal sites, concentrations, and time points. Considering the additional physiological changes induced by inflammation, hormones, and semen deposition, it is an enormous challenge to design relevant experimental models for evaluating prophylactic compounds or biological events. Studies in mucosal samples of HIV‐exposed seronegative individuals are among the many opportunities to explore the biological events of HIV transmission under physiological circumstances.

Entities:  

Mesh:

Year:  2010        PMID: 20887223     DOI: 10.1086/655964

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection.

Authors:  Anna Månberg; Frideborg Bradley; Ulrika Qundos; Brandon L Guthrie; Kenzie Birse; Laura Noël-Romas; Cecilia Lindskog; Rose Bosire; James Kiarie; Carey Farquhar; Adam D Burgener; Peter Nilsson; Kristina Broliden
Journal:  Mol Cell Proteomics       Date:  2018-11-30       Impact factor: 5.911

Review 2.  Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications.

Authors:  Barbara L Shacklett; Ruth M Greenblatt
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

3.  HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships.

Authors:  Pauline Levinson; Robert Y Choi; Amy L Cole; Taha Hirbod; Samuel Rhedin; Barbara Payne; Brandon L Guthrie; Rose Bosire; Alexander M Cole; Carey Farquhar; Kristina Broliden
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

4.  Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.

Authors:  Kenzie D M Birse; Amy L Cole; Taha Hirbod; Lyle McKinnon; Terry B Ball; Garrett R Westmacott; Joshua Kimani; Frank Plummer; Alexander M Cole; Adam Burgener; Kristina Broliden
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

5.  Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host∶parasite interactions.

Authors:  Olivia Twu; Natalia de Miguel; Gila Lustig; Grant C Stevens; Ajay A Vashisht; James A Wohlschlegel; Patricia J Johnson
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

6.  Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.

Authors:  Rajith K R Rajoli; Henry Pertinez; Usman Arshad; Helen Box; Lee Tatham; Paul Curley; Megan Neary; Joanne Sharp; Neill J Liptrott; Anthony Valentijn; Christopher David; Steven P Rannard; Ghaith Aljayyoussi; Shaun H Pennington; Andrew Hill; Marta Boffito; Steve A Ward; Saye H Khoo; Patrick G Bray; Paul M O'Neill; W David Hong; Giancarlo A Biagini; Andrew Owen
Journal:  Br J Clin Pharmacol       Date:  2020-12-01       Impact factor: 4.335

7.  Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection.

Authors:  Kenzie M Birse; Adam Burgener; Garrett R Westmacott; Stuart McCorrister; Richard M Novak; T Blake Ball
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.